Literature DB >> 36273163

Leptospira seroprevalence and associated risk factors in healthy Swedish dogs.

Karolina Scahill1, Ulrika Windahl2, Sofia Boqvist3, Lena Pelander4.   

Abstract

BACKGROUND: Leptospirosis is an emerging zoonotic infection worldwide and a cause of life-threatening disease in dogs. Seroprevalence in Swedish dogs is unknown. The aims of the present study were to estimate seroprevalence of pathogenic Leptospira in healthy dogs in Sweden using the microagglutination test (MAT) and a rapid point-of-care enzyme-linked immunosorbent assay (ELISA), and to evaluate risk factors of Leptospira exposure in Swedish dogs.
RESULTS: Positive MAT titres (≥ 1:50) were detected in 27/369 (7.3%) of included dogs. Five different serovars were represented of which the Saxkoebing serovar was the most common (64.3%), followed by Copenhagi (14.3%), Bratislava (10.7%), Icterohaemorrhagiae (7.1%), and Canicola (3.6%). The ELISA test (SNAP® Lepto) was positive in 3/316 (0.9%) dogs. Living in urban areas and contact with stagnant water were found to be risk factors for Leptospira seropositivity (p < 0.05) in a multivariable logistic regression model.
CONCLUSION: In this first seroprevalence study of Leptospira in Swedish dogs, it was shown that healthy dogs without recent (24 months) travel history and antileptospira vaccination had been exposed to pathogenic Leptospira interrogans serovars. Contact with stagnant water and living in urban areas were independent risk factors for seropositivity.
© 2022. The Author(s).

Entities:  

Keywords:  Canine; Microagglutination test; Saxkoebing; Seropositive

Year:  2022        PMID: 36273163     DOI: 10.1186/s12917-022-03472-5

Source DB:  PubMed          Journal:  BMC Vet Res        ISSN: 1746-6148            Impact factor:   2.792


  25 in total

1.  Meta-analysis of risk factors for canine leptospirosis.

Authors:  Tamara Ricardo; M Andrea Previtali; Marcelo Signorini
Journal:  Prev Vet Med       Date:  2020-06-15       Impact factor: 2.670

Review 2.  Leptospirosis: a zoonotic disease of global importance.

Authors:  Ajay R Bharti; Jarlath E Nally; Jessica N Ricaldi; Michael A Matthias; Monica M Diaz; Michael A Lovett; Paul N Levett; Robert H Gilman; Michael R Willig; Eduardo Gotuzzo; Joseph M Vinetz
Journal:  Lancet Infect Dis       Date:  2003-12       Impact factor: 25.071

Review 3.  Canine leptospirosis--do we have a problem?

Authors:  Geneviève André-Fontaine
Journal:  Vet Microbiol       Date:  2006-04-18       Impact factor: 3.293

Review 4.  Control of canine leptospirosis in Europe: time for a change?

Authors:  W A Ellis
Journal:  Vet Rec       Date:  2010-10-16       Impact factor: 2.695

5.  Highly Pathogenic Leptospira Found in Urban Brown Rats (Rattus norvegicus) in the Largest Cities of Sweden.

Authors:  Tanja M Strand; Mare Löhmus; Thomas Persson Vinnersten; Therese Råsbäck; Karin Sundström; Tomas Bergström; Åke Lundkvist
Journal:  Vector Borne Zoonotic Dis       Date:  2015-11-18       Impact factor: 2.133

Review 6.  European consensus statement on leptospirosis in dogs and cats.

Authors:  S Schuller; T Francey; K Hartmann; M Hugonnard; B Kohn; J E Nally; J Sykes
Journal:  J Small Anim Pract       Date:  2015-03       Impact factor: 1.522

Review 7.  Leptospirosis: a neglected tropical zoonotic infection of public health importance-an updated review.

Authors:  Krishnan Baby Karpagam; Balasubramanian Ganesh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-01-02       Impact factor: 3.267

8.  Clinical findings in dogs diagnosed with leptospirosis in England.

Authors:  Jennifer Raj; Ruth Campbell; Simon Tappin
Journal:  Vet Rec       Date:  2021-06-04       Impact factor: 2.695

9.  Leptospira seroprevalence in owned dogs from Spain.

Authors:  M C López; A Vila; J Rodón; X Roura
Journal:  Heliyon       Date:  2019-08-27

10.  Evaluation of changes in the epidemiology of leptospirosis in dogs after introduction of a quadrivalent antileptospiral vaccine in a highly endemic area.

Authors:  Thierry Francey; Ariane Schweighauser; Antonella Reber; Simone Schuller
Journal:  J Vet Intern Med       Date:  2020-10-26       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.